Scope Diagnostic
 |
 Olympus A2212 diagnostic scope Sheath A0404 Obturator $126.00 Time Remaining: 15d 19h 45m Buy It Now for only: $126.00 |
 National Scope Illuminated Scope Set Otoscope Throat Eyes Diagnostic Inspection $40.00 Time Remaining: 1d 17h 36m Buy It Now for only: $40.00 |
 Olympus A2210 diagnostic scope Sheath and Obturator $236.00 Time Remaining: 26d 22h 35m Buy It Now for only: $236.00 |
 ARTHROTEK INNERVUE DIAGNOSTIC SCOPE SYSTEM MODEL IV1 $2,500.00 Time Remaining: 7d 13h 46m Buy It Now for only: $2,500.00 |
 Riester Ri Scope L Diagnostic SetOtoscope L2 Ophthalmoscope L135V 3748003 $438.90 Time Remaining: 23h 8m Buy It Now for only: $438.90 |
 Riester Ri Scope L Diagnostic SetOtoscope L3 Ophthalmoscope L235V 3746003 $361.44 Time Remaining: 23h 16m Buy It Now for only: $361.44 |
 Riester Ri Scope L Diagnostic Set Otoscope L2 35V $327.18 Time Remaining: 23h 11m Buy It Now for only: $327.18 |
Scope Diagnostic
Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
The key factor in the current scenario for next-generation omics-based diagnostic technologies is the level of accuracy in the results, followed by the capacity to detect early, and cost. Cost currently remains a major constraint, as people and healthcare institutes are skeptical of investing in technologies that have not provided very wide and acceptable results. The impact of cost constraints will diminish as the cost/value benefit is established. The future market will demand reliability, which means reproducible results on standard equipment, and techniques with less deviation across laboratories and methodologies. The importance of accuracy remains constant. Industry participants will continue to position their diagnostic products based on accuracy levels. Emphasis will also remain on its capacity to test the probability of disease as early as possible through a non-invasive method of diagnosis.
The report discusses drivers, restraints, challenges and opportunities and market estimates of the global diagnostics market in genomics, proteomics and metabolomics on the basis of:
• Technologies
• Applications
• Strategic issues and innovations
Key features of this report
• Measures the global diagnostics market with respect to technologies and applications
• Analyzes the market with respect to drivers, restraints, challenges, opportunities and market estimates
• Identifies trends and innovations in the markets analyzed
• Analyzes and forecasts the revenues of regional market segments
• In-depth analysis of competitive landscape, top-selling products and services
Scope of this report
• Understanding the existing and emerging applications of diagnostic in the three omics technologies of proteomics, genomics and metabolomics.
• Analyses of the products and technological developments in the market.
• Understanding of the various applications and their importance in the development of new diagnostics products
• Many novel tests such as mass spectrometry and microarrays are expected to make a significant difference in the prognosis, monitoring and diagnosis of cancer patients..
Key Market Issues
• Past and current trends are still dominated by symptom based diagnosis.
• However, current healthcare objectives focus on early detection.
• The future is about genetic study and disease pre-disposition, which will test the probability of acquiring a disease or a disorder, enabling precautionary steps.
• Evolving technology development based on omics technologies are making diagnostic tests less expensive.
• Accuracy remains the key demand for next generation omics based diagnostics.
Key findings from this report
• Mass spectrometry is used to identify potential circulating protein biomarkers for non-small cell lung cancer.
• Omics and diagnostics have been helpful in the diagnosis of H1N1, but genome-based techniques have proved vital in identifying the strain of the virus.
• Genome sequencing remains the most challenging task, as it requires a great deal of time and investment.
• Biomarkers in omics have contributed greatly to the early diagnosis of cancer.
Key questions answered
• What are the existing and pipeline technologies and products in the diagnostics market?
• What are the major application areas of diagnostics?
• What are the key market developments of the top companies profiled in this report?
• What are the trends and innovations in the global diagnostics market?
To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/3860/Genomics-Proteomics-and-Metabolomics-in-Diagnostics-Market-landscape-innovative-technologies-and-future-outlook.html
Contact us:
Visionshopsters
Ph : 91-22-40583020
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com
About the Author
Visionshopsters specializes in providing comprehensive collection of online market research reports, events bookings, country reports, company profiles, latest books and magazines, customized research services offering informative solutions worldwide. We constantly believe in providing inventive solutions to clients all across the globe. Our clientele consists of over thousands of top most academic organizations, financial institutions, trading companies, legal service providers, accounting consultancies and other corporate business executives.
Does anybody know of a good diagnostic program?
I need to find a diagnostic program to distinguish between software / hardware related issues. It is for a corporate environment, so price is not really key here.
*Also, does anybody have any comments about Micro-Scope?
..For diagnostic program:Sandra2007 ...is available in pro- lite-home and busines ...It is a good program..Probably the best on the net...
About Micro-Scope: I put a link at the bottom...
Greetings...
Using the Scan Tool and Labscope with the OTC Pegisys PART 1